Prestige Consumer Healthcare Inc.
PBH- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001295947
No open-market purchases or sales by Prestige Consumer Healthcare Inc. insiders were filed in the last 90 days; 319 institutions reported holding it in 13F filings for Q2 2026, worth $2.54B in total; Maverick Capital is the only superinvestor holding it.
13F holders, Q3 2024
Institutional positions in Prestige Consumer Healthcare Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 327
- +24 vs. Q2 2024
- Shares held
- 51.1M
- +8.30M (+19.4%) vs. Q2 2024
- Total value
- $3.68B
- +$740.1M (+25.1%) vs. Q2 2024
- New holders
- 45
- 120 more added
- Sold out
- 21
- 104 more reduced
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PBH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 319 | $2.54B |
| Q1 2026 | 354 | $3.08B |
| Q4 2025 | 354 | $3.18B |
| Q3 2025 | 356 | $3.17B |
| Q2 2025 | 377 | $4.16B |
| Q1 2025 | 358 | $4.44B |
| Q4 2024 | 337 | $4.10B |
| Q3 2024 | 327 | $3.68B |
| Q2 2024 | 305 | $3.51B |
| Q1 2024 | 312 | $3.72B |
| Q4 2023 | 288 | $3.13B |
| Q3 2023 | 280 | $2.91B |
| Q2 2023 | 278 | $2.97B |
| Q1 2023 | 283 | $3.16B |
| Q4 2022 | 288 | $3.13B |
| Q3 2022 | 276 | $2.49B |
| Q2 2022 | 285 | $2.98B |
| Q1 2022 | 286 | $2.67B |
| Q4 2021 | 271 | $3.07B |
| Q3 2021 | 248 | $2.85B |
| Q2 2021 | 227 | $2.71B |
| Q1 2021 | 240 | $2.32B |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Prestige Consumer Healthcare Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Leeward Investments, LLC - MA | 404,728 | $29.2M | 1.35% | −1,365−0.3% | Reduced |
| Jennison Associates LLC | 410,937 | $29.6M | 0.02% | −15,378−3.6% | Reduced |
| FMR LLC | 438,149 | $31.6M | 0.00% | −566,804−56.4% | Reduced |
| Price T Rowe Associates Inc | 453,406 | $32.7M | 0.00% | +7,496+1.7% | Added |
| Eagle Asset Management Inc | 434,514 | $34.9M | 0.18% | +3,227+0.7% | Added |
| Norges Bank | 504,784 | $36.4M | 0.01% | 00.0% | Unchanged |
| Manufacturers Life Insurance Company, The | 540,913 | $39.0M | 0.03% | −2,488−0.5% | Reduced |
| Bank of America Corp | 558,268 | $40.3M | 0.00% | +40,134+7.7% | Added |
| Rice Hall James & Associates, LLC | 573,534 | $41.4M | 2.24% | −18,723−3.2% | Reduced |
| Boston Trust Walden Corp | 579,538 | $41.8M | 0.29% | +579,538 | New |
| Charles Schwab Investment Management Inc | 602,176 | $43.4M | 0.01% | −63,650−9.6% | Reduced |
| Aristotle Capital Boston, LLC | 647,545 | $46.7M | 1.55% | −11,264−1.7% | Reduced |
| Massachusetts Financial Services Co | 729,830 | $52.6M | 0.02% | −83,277−10.2% | Reduced |
| Northern Trust Corp | 733,021 | $52.9M | 0.01% | +1,158+0.2% | Added |
| Westwood Holdings Group Inc. | 859,988 | $62.0M | 0.26% | −48,472−5.3% | Reduced |
| Congress Asset Management Co | 865,123 | $62.4M | 0.43% | +62,411+7.8% | Added |
| Invesco Ltd. | 1,035,871 | $74.7M | 0.01% | −42,247−3.9% | Reduced |
| Morgan Stanley | 1,120,139 | $80.8M | 0.01% | +191,767+20.7% | Added |
| Geode Capital Management, LLC | 1,326,794 | $95.7M | 0.01% | +50,961+4.0% | Added |
| Allspring Global Investments Holdings, LLC | 1,575,170 | $113.6M | 0.18% | +255,045+19.3% | Added |
| State Street Corp | 2,006,172 | $144.6M | 0.01% | −5,871−0.3% | Reduced |
| Victory Capital Management Inc | 2,067,908 | $149.1M | 0.14% | −6,552−0.3% | Reduced |
| Macquarie Group Ltd | 2,674,484 | $192.8M | 0.21% | −162,363−5.7% | Reduced |
| Ariel Investments, LLC | 2,782,840 | $200.6M | 2.05% | −52,363−1.8% | Reduced |
| Dimensional Fund Advisors LP | 2,959,018 | $213.3M | 0.05% | −48,306−1.6% | Reduced |
| Vanguard Group Inc | 5,682,031 | $409.7M | 0.01% | −16,592−0.3% | Reduced |
| BlackRock, Inc. | 8,192,542 | $590.7M | 0.01% | +8,192,542 | New |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −123,920−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −100,246−100.0% | Sold out |
| Landscape Capital Management, L.L.C. | 0 | $0 | 0.00% | −58,075−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −14,873−100.0% | Sold out |
| Eisler Capital (US) LLC | 0 | $0 | 0.00% | −11,836−100.0% | Sold out |
| UniSuper Management Pty Ltd | 0 | $0 | 0.00% | −11,171−100.0% | Sold out |
| Lombard Odier Asset Management (USA) Corp | 0 | $0 | 0.00% | −7,994−100.0% | Sold out |
| Foundry Partners, LLC | 0 | $0 | 0.00% | −6,079−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −4,924−100.0% | Sold out |
| Lido Advisors, LLC | 0 | $0 | 0.00% | −4,057−100.0% | Sold out |
| Innealta Capital, LLC | 0 | $0 | 0.00% | −1,731−100.0% | Sold out |
| Gladius Capital Management LP | 0 | $0 | 0.00% | −513−100.0% | Sold out |
| Opal Wealth Advisors, LLC | 0 | $0 | 0.00% | −377−100.0% | Sold out |
| Headlands Technologies LLC | 0 | $0 | 0.00% | −342−100.0% | Sold out |
| Crewe Advisors LLC | 0 | $0 | 0.00% | −231−100.0% | Sold out |
| Triad Wealth Partners, LLC | 0 | $0 | 0.00% | −60−100.0% | Sold out |
| Stephens Consulting, LLC | 0 | $0 | 0.00% | −56−100.0% | Sold out |
| Cypress Capital, LLC | 0 | $0 | 0.00% | −35−100.0% | Sold out |
| RFP Financial Group LLC | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| Lynx Investment Advisory | 0 | $0 | 0.00% | −19−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −11−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |
| Sofos Investments, Inc. | – | – | – | – | Not filed |